We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine Product List and Ranking from 31 Manufacturers, Suppliers and Companies

Last Updated： Aggregation Period:Sep 24, 2025～Oct 21, 2025
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Sep 24, 2025～Oct 21, 2025
This ranking is based on the number of page views on our site.

  1. マーケットリサーチセンター Tokyo//Service Industry
  2. スペラファーマ Osaka//others
  3. null/null
  4. 4 ケーナインラボ Tokyo//Testing, Analysis and Measurement
  5. 5 リボミック Tokyo//others
Go to Company Ranking

medicine Product ranking

Last Updated： Aggregation Period:Sep 24, 2025～Oct 21, 2025
This ranking is based on the number of page views on our site.

  1. Contract development and manufacturing (CDMO) business for mid-sized molecules (oligonucleotides and peptides) active pharmaceutical ingredients.
  2. K9 Lab Inc. Company Profile ケーナインラボ
  3. [Knowledge of Traditional Chinese Medicine] Basic Functions of Herbal Medicine (3) 'Rising, Falling, Floating, Sinking' 福田龍 本社
  4. Cavity prevention medicine Gurupepr カツマタ 医薬品製造販売部
  5. 4 Development of various types of medium-sized molecule (nucleic acid, peptide) pharmaceuticals (processes, analytical methods, etc.)

medicine Product List

556～570 item / All 584 items

Displayed results
[Research Material] The Global Market for von Willebrand Disease (VWD) Treatments

[Research Material] The Global Market for von Willebrand Disease (VWD) Treatments

World Market for Von Willebrand Disease (VWD) Treatments: Desmopressin, Thrombus Stabilization Drugs, Fibrinolysis Inhibitors, Replacement Therapy, Others, Hospitals ...

This research report (Global Von Willebrand Disease (VWD) Therapeutics M) investigates and analyzes the current status and outlook for the global market of Von Willebrand disease (VWD) therapeutics over the next five years. It includes information on the overview of the global Von Willebrand disease (VWD) therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type for Von Willebrand disease (VWD) therapeutics include desmopressin, thrombin stabilizers, fibrinolysis inhibitors, replacement therapy, and others, while the segments by application target hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments calculate the market size for Von Willebrand disease (VWD) therapeutics by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in Von Willebrand disease (VWD) therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Cancer Anorexia-Cachexia Syndrome Treatment Drugs

[Research Material] Global Market for Cancer Anorexia-Cachexia Syndrome Treatment Drugs

Cancer-related anorexia-cachexia syndrome treatment drugs global market: NEO-1940, C-1889, DLN-101, Foxo1-nRNA, AVG ...

This research report (Global Cancer Anorexia-Cachexia Syndrome Drug Market) investigates and analyzes the current status and outlook for the global market of cancer anorexia-cachexia syndrome treatment drugs over the next five years. It includes information on the overview of the global cancer anorexia-cachexia syndrome treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include NEO-1940, C-1889, DLN-101, Foxo1-nRNA, AVGN-7, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for cancer anorexia-cachexia syndrome treatment drugs. It also includes the market share of major companies in the cancer anorexia-cachexia syndrome treatment drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Postmenopausal Vaginal Atrophy (PVA) Treatment

[Research Material] The Global Market for Postmenopausal Vaginal Atrophy (PVA) Treatment

Postmenopausal Vaginal Atrophy (PVA) Treatment Global Market: Drug Therapy, Other Treatments, Hospitals, Clinics, Others

This research report (Global Postmenopausal Vaginal Atrophy (PVA) Therap) investigates and analyzes the current state and outlook for the global market for postmenopausal vaginal atrophy (PVA) treatment over the next five years. It includes information on the overview of the global postmenopausal vaginal atrophy (PVA) treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for postmenopausal vaginal atrophy (PVA) treatment by type include drug treatments and other therapies, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for postmenopausal vaginal atrophy (PVA) treatment. It also includes the market share of major companies in postmenopausal vaginal atrophy (PVA) treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Retinal Disorder Treatments

[Research Material] Global Market for Retinal Disorder Treatments

Global Market for Retinal Disorder Treatments: Gels, Capsules & Tablets, Eye Drops, Ointments, Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

This research report (Global Retinal Disorder Treatment Market) investigates and analyzes the current state and outlook for the global market for retinal disorder treatments over the next five years. It includes information on the overview of the global retinal disorder treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include gels, capsules & tablets, eye drops, and ointments, while the segments by application focus on hospital pharmacies, online pharmacies, and retail pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for retinal disorder treatments. It also includes the market share of major companies in retinal disorder treatments, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Critical Limb Ischemia Treatment Drugs

[Research Material] Global Market for Critical Limb Ischemia Treatment Drugs

World Market for Critical Limb Ischemia Therapeutics: HC-016, JVS-100, NFx-101, NK-104 NP, Others, Hospitals, etc.

This research report (Global Critical Limb Ischemia Drug Market) investigates and analyzes the current status and outlook for the global market of critical limb ischemia treatment drugs over the next five years. It includes information on the overview of the global critical limb ischemia treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include HC-016, JVS-100, NFx-101, NK-104 NP, and others, while the segments by application focus on hospitals, home care, and ASCs. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for critical limb ischemia treatment drugs. It also includes the market share of major companies in the critical limb ischemia treatment drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Vasculitis Treatment Drugs

[Research Material] Global Market for Vasculitis Treatment Drugs

World Market for Vasculitis Treatment Drugs: Brisibimod, CCX-168, Gebokizumab, Rituximab Biosimilar, Others, Nodular Polyarteritis ...

This research report (Global Vasculitis Drug Market) investigates and analyzes the current status and outlook for the global market for vasculitis treatment drugs over the next five years. It includes information on the global vasculitis treatment drug market overview, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Brisibimod, CCX-168, Gebokizumab, Rituximab biosimilars, and others, while the segments by application cover Nodular Polyarteritis, Thrombotic Vasculitis, Granulomatous Vasculitis, Lymphocytic Vasculitis, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for vasculitis treatment drugs. It also includes the market share of major companies in the vasculitis treatment drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Osteoporosis Treatment Drugs

[Research Material] Global Market for Osteoporosis Treatment Drugs

Global Market for Osteoporosis Treatments: Absorption Inhibitors, Anabolic Drugs, Women, Men

This research report (Global Osteoporosis Drugs Market) investigates and analyzes the current state and outlook for the global market for osteoporosis treatment drugs over the next five years. It includes information on the overview of the global osteoporosis treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include absorption inhibitors and anabolic drugs, while the segments by application focus on women and men. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for osteoporosis treatment drugs. It also includes the market share of major companies in osteoporosis treatment drugs, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Oral Cancer Treatment

[Research Material] Global Market for Oral Cancer Treatment

Global Market for Oral Cancer Treatment: Squamous Cell Carcinoma, Verrucous Carcinoma, Minor Salivary Gland Cancer, Lymphoma, Hospitals & Clinics, Research Institutions, Academic Institutions

This research report (Global Oral Cancer Treatment Market) investigates and analyzes the current status and outlook for the global oral cancer treatment market over the next five years. It includes information on the overview of the global oral cancer treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the oral cancer treatment market include squamous cell carcinoma, verrucous carcinoma, minor salivary gland carcinoma, and lymphoma, while the segments by application focus on hospitals/clinics, research institutions, and academic institutions. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for oral cancer treatment. It also includes the market share of major companies in oral cancer treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Jet Lag Treatment

[Research Material] The Global Market for Jet Lag Treatment

Global Market for Jet Lag Treatment: Prescription, OTC, Hospital Pharmacies, Retail Pharmacies, Online

This research report (Global Jet Lag Treatment Market) investigates and analyzes the current status and outlook for the global jet lag treatment market over the next five years. It includes information on the overview of the global jet lag treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the jet lag treatment market focus on prescription and OTC, while the segments by application target hospital pharmacies, retail pharmacies, and online sales. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for jet lag treatment. It also includes the market share of major companies in jet lag treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatment of Secondary Progressive Multiple Sclerosis

[Research Material] Global Market for Treatment of Secondary Progressive Multiple Sclerosis

World Market for Treatment of Secondary Progressive Multiple Sclerosis: Inebilizumab, GLX-1112, DC-TAB, Etomoxir, IB-MS, and others...

This research report (Global Secondary Progressive Multiple Sclerosis Drug Market) investigates and analyzes the current state and outlook for the global market of secondary progressive multiple sclerosis treatment drugs over the next five years. It includes information on the overview of the global secondary progressive multiple sclerosis treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Inebilizumab, GLX-1112, DC-TAB, Etomoxir, IB-MS, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for secondary progressive multiple sclerosis treatment drugs. It also includes the market share of major companies in the secondary progressive multiple sclerosis treatment drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Drugs for Chemotherapy-Induced Nausea and Vomiting (CINV)

[Research Material] Global Market for Drugs for Chemotherapy-Induced Nausea and Vomiting (CINV)

World Market for Chemotherapy-Induced Nausea and Vomiting (CINV) Drugs: 5-HT3 Inhibitors, NK1 Inhibitors, Others, Highly Emetogenic Chemotherapy, Moderately Emetogenic Chemotherapy ...

This research report (Global Chemotherapy Induced Nausea and Vomiting (C)) investigates and analyzes the current status and outlook for the global market of drugs for chemotherapy-induced nausea and vomiting (CINV) over the next five years. It includes information on the global overview of the chemotherapy-induced nausea and vomiting (CINV) drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for chemotherapy-induced nausea and vomiting (CINV) drugs by type include 5-HT3 antagonists, NK1 antagonists, and others, while the segments by application cover highly emetogenic chemotherapy, moderately emetogenic chemotherapy, low emetogenic chemotherapy, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, calculating the market size for chemotherapy-induced nausea and vomiting (CINV) drugs. It also includes the market share of major companies in the chemotherapy-induced nausea and vomiting (CINV) drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Head and Neck Cancer Treatments

[Research Material] Global Market for Head and Neck Cancer Treatments

Global Market for Head and Neck Cancer Treatments: PD Inhibitors, Microtubule Inhibitors, EGFR Inhibitors, Surgery, Radiation Therapy, Chemotherapy, Immunotherapy

This research report (Global Head and Neck Cancer Therapeutics Market) investigates and analyzes the current state and outlook for the global market for head and neck cancer therapeutics over the next five years. It includes information on the overview of the global head and neck cancer therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include PD inhibitors, microtubule inhibitors, and EGFR inhibitors, while the segments by application focus on surgery, radiation therapy, chemotherapy, and immunotherapy. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for head and neck cancer therapeutics. It also includes the market share of major companies in head and neck cancer therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Argininemia Treatment

[Research Material] The Global Market for Argininemia Treatment

Global Market for Argininemia Treatment: Oral, Injection, Hospitals, Drugstores, Others

This research report (Global Argininemia Treatment Market) investigates and analyzes the current state and outlook for the global argininemia treatment market over the next five years. It includes information on the overview of the global argininemia treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the argininemia treatment market focus on oral and injectable forms, while the segments by application target hospitals, drugstores, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for argininemia treatment. It also includes the market share of major companies in the argininemia treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Friedrich's Ataxia Treatment Drugs

[Research Material] Global Market for Friedrich's Ataxia Treatment Drugs

Global Market for Friedreich's Ataxia Treatment Drugs: ADVM-063, AGIL-FA, BHV-4157, BVA-202, and others, etc.

This research report (Global Friedreich Ataxia Drug Market) investigates and analyzes the current state and outlook for the global market of Friedreich's ataxia treatment drugs over the next five years. It includes information on the overview of the global Friedreich's ataxia treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include ADVM-063, AGIL-FA, BHV-4157, BVA-202, and others, while the segments by application focus on clinics, hospitals, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Friedreich's ataxia treatment drugs. It also includes the market share of major companies in Friedreich's ataxia treatment drugs, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Pseudomonas Aeruginosa Infection Treatment

[Research Material] Global Market for Pseudomonas Aeruginosa Infection Treatment

Global Market for Pseudomonas Aeruginosa Infection Treatment: Nasal, Oral, Intravenous, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

This research report (Global Pseudomonas Aeruginosa Infection Treatment) investigates and analyzes the current state and future outlook of the global market for Pseudomonas aeruginosa infection treatment over the next five years. It includes information on the overview of the global Pseudomonas aeruginosa infection treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on nasal, oral, and intravenous treatments, while the segments by application target hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments calculate the market size for Pseudomonas aeruginosa infection treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in Pseudomonas aeruginosa infection treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.